CAMBRIDGE, Mass., June 2, 2018 /PRNewswire-USNewswire/ — Why is it so hard to develop drugs for children with cancer? And what can be done about it?
Those questions are central to a new study published today in JAMA Oncology that explores new business models for funding drug…



Source link